1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Biosimilars/Follow-on-Biologics Revenue
1.4 Market Analysis by Type
1.4.1 Global Biosimilars/Follow-on-Biologics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Human growth hormone
1.4.3 Erythropoietin
1.4.4 Monoclonal antibodies
1.4.5 Insulin
1.4.6 Interferon
1.4.7 Granulocyte-Colony Stimulating Factor
1.4.8 Peptide
1.4.9 Others
1.5 Market by Application
1.5.1 Global Biosimilars/Follow-on-Biologics Market Share by Application: 2021-2026
1.5.2 Blood disorders
1.5.3 Oncology diseases
1.5.4 Chronic and autoimmune diseases
1.5.5 Growth hormone deficiencies
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Biosimilars/Follow-on-Biologics Market
1.8.1 Global Biosimilars/Follow-on-Biologics Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Biosimilars/Follow-on-Biologics Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Biosimilars/Follow-on-Biologics Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Biosimilars/Follow-on-Biologics Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Biosimilars/Follow-on-Biologics Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Biosimilars/Follow-on-Biologics Sales Volume Market Share by Region (2015-2020)
3.2 Global Biosimilars/Follow-on-Biologics Sales Revenue Market Share by Region (2015-2020)
3.3 North America Biosimilars/Follow-on-Biologics Sales Volume
3.3.1 North America Biosimilars/Follow-on-Biologics Sales Volume Growth Rate (2015-2020)
3.3.2 North America Biosimilars/Follow-on-Biologics Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Biosimilars/Follow-on-Biologics Sales Volume
3.4.1 East Asia Biosimilars/Follow-on-Biologics Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Biosimilars/Follow-on-Biologics Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Biosimilars/Follow-on-Biologics Sales Volume (2015-2020)
3.5.1 Europe Biosimilars/Follow-on-Biologics Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Biosimilars/Follow-on-Biologics Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Biosimilars/Follow-on-Biologics Sales Volume (2015-2020)
3.6.1 South Asia Biosimilars/Follow-on-Biologics Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Biosimilars/Follow-on-Biologics Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Biosimilars/Follow-on-Biologics Sales Volume (2015-2020)
3.7.1 Southeast Asia Biosimilars/Follow-on-Biologics Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Biosimilars/Follow-on-Biologics Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Biosimilars/Follow-on-Biologics Sales Volume (2015-2020)
3.8.1 Middle East Biosimilars/Follow-on-Biologics Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Biosimilars/Follow-on-Biologics Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Biosimilars/Follow-on-Biologics Sales Volume (2015-2020)
3.9.1 Africa Biosimilars/Follow-on-Biologics Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Biosimilars/Follow-on-Biologics Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Biosimilars/Follow-on-Biologics Sales Volume (2015-2020)
3.10.1 Oceania Biosimilars/Follow-on-Biologics Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Biosimilars/Follow-on-Biologics Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Biosimilars/Follow-on-Biologics Sales Volume (2015-2020)
3.11.1 South America Biosimilars/Follow-on-Biologics Sales Volume Growth Rate (2015-2020)
3.11.2 South America Biosimilars/Follow-on-Biologics Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Biosimilars/Follow-on-Biologics Sales Volume (2015-2020)
3.12.1 Rest of the World Biosimilars/Follow-on-Biologics Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Biosimilars/Follow-on-Biologics Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Biosimilars/Follow-on-Biologics Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Biosimilars/Follow-on-Biologics Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Biosimilars/Follow-on-Biologics Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Biosimilars/Follow-on-Biologics Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Biosimilars/Follow-on-Biologics Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Biosimilars/Follow-on-Biologics Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Biosimilars/Follow-on-Biologics Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Biosimilars/Follow-on-Biologics Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Biosimilars/Follow-on-Biologics Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Biosimilars/Follow-on-Biologics Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Biosimilars/Follow-on-Biologics Sales Volume Market Share by Type (2015-2020)
14.2 Global Biosimilars/Follow-on-Biologics Sales Revenue Market Share by Type (2015-2020)
14.3 Global Biosimilars/Follow-on-Biologics Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Biosimilars/Follow-on-Biologics Consumption Volume by Application (2015-2020)
15.2 Global Biosimilars/Follow-on-Biologics Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Biosimilars/Follow-on-Biologics Business
16.1 Novartis
16.1.1 Novartis Company Profile
16.1.2 Novartis Biosimilars/Follow-on-Biologics Product Specification
16.1.3 Novartis Biosimilars/Follow-on-Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 Merck Group
16.2.1 Merck Group Company Profile
16.2.2 Merck Group Biosimilars/Follow-on-Biologics Product Specification
16.2.3 Merck Group Biosimilars/Follow-on-Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 LG Life Sciences
16.3.1 LG Life Sciences Company Profile
16.3.2 LG Life Sciences Biosimilars/Follow-on-Biologics Product Specification
16.3.3 LG Life Sciences Biosimilars/Follow-on-Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 Synthon Pharmaceuticals
16.4.1 Synthon Pharmaceuticals Company Profile
16.4.2 Synthon Pharmaceuticals Biosimilars/Follow-on-Biologics Product Specification
16.4.3 Synthon Pharmaceuticals Biosimilars/Follow-on-Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 Hospira
16.5.1 Hospira Company Profile
16.5.2 Hospira Biosimilars/Follow-on-Biologics Product Specification
16.5.3 Hospira Biosimilars/Follow-on-Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 Teva Pharmaceutical Industries
16.6.1 Teva Pharmaceutical Industries Company Profile
16.6.2 Teva Pharmaceutical Industries Biosimilars/Follow-on-Biologics Product Specification
16.6.3 Teva Pharmaceutical Industries Biosimilars/Follow-on-Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 Genentech (Roche Group)
16.7.1 Genentech (Roche Group) Company Profile
16.7.2 Genentech (Roche Group) Biosimilars/Follow-on-Biologics Product Specification
16.7.3 Genentech (Roche Group) Biosimilars/Follow-on-Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.8 Biocon
16.8.1 Biocon Company Profile
16.8.2 Biocon Biosimilars/Follow-on-Biologics Product Specification
16.8.3 Biocon Biosimilars/Follow-on-Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.9 Celltrion
16.9.1 Celltrion Company Profile
16.9.2 Celltrion Biosimilars/Follow-on-Biologics Product Specification
16.9.3 Celltrion Biosimilars/Follow-on-Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.10 Biogen idec, Inc.
16.10.1 Biogen idec, Inc. Company Profile
16.10.2 Biogen idec, Inc. Biosimilars/Follow-on-Biologics Product Specification
16.10.3 Biogen idec, Inc. Biosimilars/Follow-on-Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Biosimilars/Follow-on-Biologics Manufacturing Cost Analysis
17.1 Biosimilars/Follow-on-Biologics Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Biosimilars/Follow-on-Biologics
17.4 Biosimilars/Follow-on-Biologics Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Biosimilars/Follow-on-Biologics Distributors List
18.3 Biosimilars/Follow-on-Biologics Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Biosimilars/Follow-on-Biologics (2021-2026)
20.2 Global Forecasted Revenue of Biosimilars/Follow-on-Biologics (2021-2026)
20.3 Global Forecasted Price of Biosimilars/Follow-on-Biologics (2015-2026)
20.4 Global Forecasted Production of Biosimilars/Follow-on-Biologics by Region (2021-2026)
20.4.1 North America Biosimilars/Follow-on-Biologics Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Biosimilars/Follow-on-Biologics Production, Revenue Forecast (2021-2026)
20.4.3 Europe Biosimilars/Follow-on-Biologics Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Biosimilars/Follow-on-Biologics Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Biosimilars/Follow-on-Biologics Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Biosimilars/Follow-on-Biologics Production, Revenue Forecast (2021-2026)
20.4.7 Africa Biosimilars/Follow-on-Biologics Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Biosimilars/Follow-on-Biologics Production, Revenue Forecast (2021-2026)
20.4.9 South America Biosimilars/Follow-on-Biologics Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Biosimilars/Follow-on-Biologics Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Biosimilars/Follow-on-Biologics by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Biosimilars/Follow-on-Biologics by Country
21.2 East Asia Market Forecasted Consumption of Biosimilars/Follow-on-Biologics by Country
21.3 Europe Market Forecasted Consumption of Biosimilars/Follow-on-Biologics by Countriy
21.4 South Asia Forecasted Consumption of Biosimilars/Follow-on-Biologics by Country
21.5 Southeast Asia Forecasted Consumption of Biosimilars/Follow-on-Biologics by Country
21.6 Middle East Forecasted Consumption of Biosimilars/Follow-on-Biologics by Country
21.7 Africa Forecasted Consumption of Biosimilars/Follow-on-Biologics by Country
21.8 Oceania Forecasted Consumption of Biosimilars/Follow-on-Biologics by Country
21.9 South America Forecasted Consumption of Biosimilars/Follow-on-Biologics by Country
21.10 Rest of the world Forecasted Consumption of Biosimilars/Follow-on-Biologics by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer